Trang chủ › Ung thư phổi không tế bào nhỏ › Đặc khu Columbia › Washington
Thử nghiệm lâm sàng cho Ung thư phổi không tế bào nhỏ tại Washington, DC
55 nghiên cứu cho Ung thư phổi không tế bào nhỏ đang tìm kiếm người tham gia tại các cơ sở ở Washington và vùng lân cận (bán kính khoảng 30 dặm). Mở nghiên cứu để xem tiêu chí tham gia và cách liên hệ với đội ngũ nghiên cứu.
Văn bản nghiên cứu chính thức (Tiếng Anh)
Đang tuyển dụng cho một nghiên cứu? Đưa tin của bạn lên đầu trang này — $99 trong 30 ngày →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Đang tuyểnGiai đoạn 3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- và 1 nữa
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Đang tuyểnNghiên cứu quan sát
- National Institutes of Health Clinical Center, Bethesda · Cách 7 dặm
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Đang tuyểnGiai đoạn 2
- Local Institution - 0183, Washington D.C.
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Đang tuyểnGiai đoạn 3
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
A Study of PHN-012 in Patients With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- PHN-012-001 Site, Washington D.C.
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Đang tuyểnGiai đoạn 2
- Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital, Washington D.C.
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Đang tuyểnNghiên cứu quan sát
- National Institutes of Health Clinical Center, Bethesda · Cách 7 dặm
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Đang tuyểnGiai đoạn 3
- Maryland Oncology Hematology, P.A., Silver Spring · Cách 7 dặm
- Maryland Oncology Hematology, P.A., Bethesda · Cách 7 dặm
- Maryland Oncology Hematology, P.A, Largo · Cách 11 dặm
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Đang tuyểnGiai đoạn 2
- National Institutes of Health Clinical Center, Bethesda · Cách 7 dặm
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Đang tuyểnGiai đoạn 3
- Research Site, Silver Spring · Cách 7 dặm
- Research Site, Bethesda · Cách 7 dặm
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Đang tuyểnGiai đoạn 3
- Maryland Oncology Hematology, P.A., Silver Spring · Cách 7 dặm
- Maryland Oncology Hematology, P.A., Bethesda · Cách 7 dặm
- Maryland Oncology Hematology, P.A., Largo · Cách 11 dặm
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Đang tuyểnGiai đoạn 2
- MedStar Georgetown University Hospital, Washington D.C.
- Washington DC VA Medical Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · Cách 7 dặm
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Đang tuyểnGiai đoạn 2
- Georgetown University, Washington D.C.
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Đang tuyểnGiai đoạn 3
- Washington DC Veterans Affairs Medical Center, Washington D.C.
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Đang tuyểnGiai đoạn 2
- MedStar Georgetown University Hospital, Washington D.C.
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Đang tuyểnGiai đoạn 3
- Sibley Memorial Hospital, Washington D.C.
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Đang tuyểnGiai đoạn 1
- National Institutes of Health Clinical Center, Bethesda · Cách 7 dặm
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Đang tuyểnGiai đoạn 2/3
- MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), Washington D.C.
- MEDSTAR Washington Hospital Center (MedStar Health Research Institute), Washington D.C.
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Đang tuyểnGiai đoạn 1
- Georgetown University Medical Center, Washington D.C.
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Đang tuyểnGiai đoạn 3
- Research Site, Bethesda · Cách 7 dặm
- Research Site, Bethesda · Cách 7 dặm
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Đang tuyểnGiai đoạn 3
- George Washington University Cancer Center, Washington D.C.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Đang tuyểnGiai đoạn 1/2
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Đang tuyểnGiai đoạn 2/3
- Local Institution - 007-5476, Washington D.C.
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Đang tuyểnGiai đoạn 2
- MedStar Georgetown University Hospital (Lombardi Comprehensive Cancer Center), Washington D.C.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Đang tuyểnGiai đoạn 3
- Sibley Memorial Hospital, Washington D.C.
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Đang tuyểnGiai đoạn 3
- Walter Reed National Military Medical Center, Bethesda · Cách 7 dặm
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Đang tuyểnGiai đoạn 3
- Washington Hospital Center ( Site 0037), Washington D.C.
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Đang tuyểnGiai đoạn 2
- National Institutes of Health Clinical Center, Bethesda · Cách 7 dặm
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Đang tuyểnGiai đoạn 3
- Research Site, Bethesda · Cách 7 dặm
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Đang tuyểnGiai đoạn 2
- MedStar Georgetown University Hospital, Washington D.C.
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Đang tuyểnGiai đoạn 1
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Đang tuyểnGiai đoạn 3
- Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Đang tuyểnGiai đoạn 1/2
- National Institutes of Health, Bethesda · Cách 7 dặm
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Đang tuyểnGiai đoạn 1/2
- Georgetown University - Lombardi Comprehensive Cancer Center, Washington D.C.
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
Đang tuyểnGiai đoạn 1/2
- Georgetown University Medical Center, Washington D.C.
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
Đang tuyểnGiai đoạn 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Đang tuyểnGiai đoạn 1/2
- Georgetown University, Washington D.C.
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Đang tuyểnGiai đoạn 1
- Maryland Oncology Hematology, Calverton · Cách 12 dặm
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Đang tuyểnGiai đoạn 1/2
- Georgetown University Medical Center, Washington D.C.
Gilteritinib for the Treatment of ALK NSCLC
Đang tuyểnGiai đoạn 1
- Georgetown University, Washington D.C.
Study of XB010 in Subjects With Solid Tumors
Đang tuyểnGiai đoạn 1
- Georgetown University Medical Center, Washington D.C.
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Đang tuyểnGiai đoạn 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · Cách 11 dặm
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Đang tuyểnGiai đoạn 2
- USA11-0, Bethesda · Cách 7 dặm
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Đang tuyểnGiai đoạn 3
- Georgetown University Medical Cener (GUMC), Washington D.C.
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Đang tuyểnGiai đoạn 3
- Research Site, Washington D.C.
- Research Site, Bethesda · Cách 7 dặm
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Đang tuyểnGiai đoạn 2/3
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · Cách 11 dặm
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Đang tuyểnGiai đoạn 2
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- Kaiser Permanente - Largo Medical Center, Largo · Cách 11 dặm
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Đang tuyểnGiai đoạn 1/2
- Sibley Memorial Hospital, Washington D.C.
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
Đang tuyểnGiai đoạn 2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
- Medstar Washington Hospital Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Đang tuyểnGiai đoạn 1
- National Cancer Institute, Bethesda · Cách 7 dặm
Repositioning Immunotherapy in VetArans With Lung Cancer
Đang tuyểnGiai đoạn 2
- VA Central Office, Washington, DC, Washington D.C.
GEMINI-NSCLC: NSCLC Biomarker Study
Đang tuyểnNghiên cứu quan sát
- The Center for Cancer and Blood Disorder, Bethesda · Cách 7 dặm
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Đang tuyểnGiai đoạn 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Đang tuyểnNghiên cứu quan sát
- Massive Bio SYNERGY-AI site, Silver Spring · Cách 7 dặm
- Massive Bio SYNERGY-AI site, Bethesda · Cách 7 dặm
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
Đang tuyểnGiai đoạn 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Thử nghiệm cho Ung thư phổi không tế bào nhỏ tại các thành phố khác
- Houston, TX145 nghiên cứu
- New York City, NY121 nghiên cứu
- Arlington, VA104 nghiên cứu
- Nashville, TN97 nghiên cứu
- Boston, MA90 nghiên cứu
- Los Angeles, CA87 nghiên cứu
- St. Louis, MO73 nghiên cứu
- Chicago, IL61 nghiên cứu
- Baltimore, MD60 nghiên cứu
- San Antonio, TX59 nghiên cứu
- Columbus, OH57 nghiên cứu
- Seattle, WA53 nghiên cứu
Các nghiên cứu khác tại Washington
- Ung thư (mọi loại)58 nghiên cứu
- Ung thư vú46 nghiên cứu
- Ung thư di căn43 nghiên cứu
- Ung thư phổi41 nghiên cứu
- Ung thư tuyến tiền liệt38 nghiên cứu
- Béo phì33 nghiên cứu
- Ung thư đại trực tràng29 nghiên cứu
- Bệnh tim mạch28 nghiên cứu
- Ung thư bàng quang26 nghiên cứu
- Bạch cầu tủy cấp24 nghiên cứu
- Ung thư buồng trứng23 nghiên cứu
- U lympho23 nghiên cứu
Nguồn dữ liệu từ ClinicalTrials.gov, cập nhật ngày 6 thg 10, 2026. Mỗi nghiên cứu có tiêu chí riêng; đội ngũ nghiên cứu sẽ quyết định ai đủ điều kiện tham gia.